Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

GaingelsLatest Sep 3

Superluminal Medicines · $60M Series B Kanvas Biosciences · $48M Series A

4rounds

0led

Biotech 4

Series A 2, Series B 1, Series C+ 1

Sep 3, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series B 1, Series C+ 1

Superluminal Medicines $60M Series B Kanvas Biosciences $48M Series A Latus Bio, Inc. $97M Series A

Cormorant Asset ManagementLatest Aug 10

Epicrispr Biotechnologies · $90M Series C Crystalys Therapeutics · $130M Series B

4rounds

—led

Biotech 4

Series C+ 3, Series B 1

Aug 10, 2026

Details

New companies 4 · Follow-on 0

Stages: Series C+ 3, Series B 1

Epicrispr Biotechnologies $90M Series C Crystalys Therapeutics $130M Series B Terremoto Biosciences $108M Series C

Duquesne Family OfficeLatest Aug 10

Epicrispr Biotechnologies · $90M Series C Ratio Therapeutics · $70M Series C

4rounds

—led

Biotech 4

Series C+ 3, Series B 1

Aug 10, 2026

Details

New companies 4 · Follow-on 0

Stages: Series C+ 3, Series B 1

Epicrispr Biotechnologies $90M Series C Ratio Therapeutics $70M Series C SonoThera $125M Series B

Wellington ManagementLatest Jul 22

Crystalys Therapeutics · $130M Series B RQ Bio · $115M Series A

4rounds

—led

Biotech 4

Series A 3, Series B 1

Jul 22, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 3, Series B 1

Crystalys Therapeutics $130M Series B RQ Bio $115M Series A Korsana Biosciences $175M Series A

YosemiteLatest Jul 13

Chai Discovery · $400M Series C HistoSonics · Undisclosed Strategic

4rounds

—led

Biotech 2AI 1Healthtech 1

Undisclosed 3, Series C+ 1

Jul 13, 2026

Details

New companies 4 · Follow-on 0

Stages: Undisclosed 3, Series C+ 1

Chai Discovery $400M Series C HistoSonics Undisclosed Strategic Ten63 Therapeutics $45M Strategic

SpeedinvestLatest Jun 23

Kyrok · €3.1M Pre-Seed Rivia · $15M Series A

4rounds

—led

Healthtech 2Agritech 1Biotech 1

Series A 2, Pre-seed 1, Seed 1

Jun 23, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Pre-seed 1, Seed 1

Kyrok €3.1M Pre-Seed Rivia $15M Series A Bindbridge $3.8M Seed

Sixty Degree CapitalLatest Jun 22

Bionyra Pharma · $165M Series A Crossbow Therapeutics · $77M Series B

4rounds

—led

Biotech 4

Series B 2, Series A 1, Series C+ 1

Jun 22, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Series A 1, Series C+ 1

Bionyra Pharma $165M Series A Crossbow Therapeutics $77M Series B Kinaset Therapeutics $103M Series B

Oncology VenturesLatest May 28

Triomics · $22M Series B NexCure · $19M Series A

4rounds

—led

Healthtech 2AI 1Biotech 1

Series A 2, Series B 1, Undisclosed 1

May 28, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series B 1, Undisclosed 1

Triomics $22M Series B NexCure $19M Series A BIOMAKERS $8M Undisclosed

LAVLatest May 18

Accro Bioscience · $50M Series C Syneron Bio · $150M Series B

4rounds

—led

Biotech 4

Seed 1, Series A 1, Series B 1, Series C+ 1

May 18, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 1, Series A 1, Series B 1, Series C+ 1

Accro Bioscience $50M Series C Syneron Bio $150M Series B Excalipoint Therapeutics $27.7M Seed+

Apricot CapitalLatest Apr 29

Vivacta Biotechnology · $50M Series A+Vivatides Therapeutics · $54M Series A

4rounds

—led

Biotech 4

Series A 3, Seed 1

Apr 29, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 3, Seed 1

Vivacta Biotechnology $50M Series A+Vivatides Therapeutics $54M Series A Excalipoint Therapeutics $27.7M Seed+

5AM VenturesLatest Oct 19

Nouscom · €120M Series D Mendra · $82M Series A

3rounds

0led

Biotech 3

Series A 1, Series B 1, Series C+ 1

Oct 19, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Series C+ 1

Nouscom €120M Series D Mendra $82M Series A Kinaset Therapeutics $103M Series B

Angelini VenturesLatest Oct 19

Nouscom · €120M Series D Aptadir Therapeutics · €40M Seed

3rounds

0led

Biotech 3

Series C+ 2, Seed 1

Oct 19, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Seed 1

Nouscom €120M Series D Aptadir Therapeutics €40M Seed Epicrispr Biotechnologies $90M Series C

Bain Capital Life SciencesLatest Oct 15

OMass Therapeutics · $310M Series C Abcuro · $66M Series D

3rounds

1led

Biotech 3

Series C+ 3

Oct 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 3

OMass Therapeutics $310M Series C Abcuro $66M Series D AdvanCell $315M Series D

Northern GritstoneLatest Oct 15

Silvia Bio · £3M Seed Imperagen · £5M Seed

3rounds

1led

Biotech 2Agritech 1

Seed 3

Oct 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 3

Silvia Bio £3M Seed Imperagen £5M Seed Cytotrait £3M Seed

Northpond VenturesLatest Oct 15

OMass Therapeutics · $310M Series C VieCure · $43M Undisclosed

3rounds

0led

Biotech 2Healthtech 1

Series A 1, Series C+ 1, Undisclosed 1

Oct 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series C+ 1, Undisclosed 1

OMass Therapeutics $310M Series C VieCure $43M Undisclosed Vizgen $48M Series A

Clean Growth FundLatest Oct 14

HydRegen · $8M Series A first close Meatly · £10.4M Series A

3rounds

0led

Foodtech 2Biotech 1

Series A 2, Undisclosed 1

Oct 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Undisclosed 1

HydRegen $8M Series A first close Meatly £10.4M Series A Clean Food Group £4.5M Undisclosed

PINCLatest Oct 14

OlsAro · €5M Seed Rainbow Crops · €9.7M Seed+

3rounds

0led

Agritech 3

Seed 2, Pre-seed 1

Oct 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 2, Pre-seed 1

OlsAro €5M Seed Rainbow Crops €9.7M Seed+Mycoverse €2.4M Pre-Seed

IQ CapitalLatest Oct 13

Undecimal Bio · $18M Seed IMU Biosciences · $53M Series A

3rounds

1led

Biotech 3

Seed 2, Series A 1

Oct 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 2, Series A 1

Undecimal Bio $18M Seed IMU Biosciences $53M Series A Imperagen £5M Seed

NVIDIALatest Oct 13

Boltz · Undisclosed Planned strategic investment Basecamp Research · $140M Series C

3rounds

0led

Biotech 3

Series B 1, Series C+ 1, Undisclosed 1

Oct 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 1, Series C+ 1, Undisclosed 1

Boltz Undisclosed Planned strategic investment Basecamp Research $140M Series C Superluminal Medicines $60M Series B

TemasekLatest Oct 13

Soufflé Therapeutics · $135M Series B Isomorphic Labs · $2.1B Series B

3rounds

0led

Biotech 3

Series B 2, Undisclosed 1

Oct 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 2, Undisclosed 1

Soufflé Therapeutics $135M Series B Isomorphic Labs $2.1B Series B Insilico Medicine $5M Strategic

AlvenLatest Oct 7

Rivercell · $25M Seed Generare · €20M Series A

3rounds

0led

Biotech 2Foodtech 1

Series A 2, Seed 1

Oct 7, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Seed 1

Rivercell $25M Seed Generare €20M Series A Verley €32M Series A

Civilization VenturesLatest Oct 6

Sensible Biotechnologies · $47M Series A Infinimmune · $75M Series A

3rounds

0led

Biotech 3

Series A 3

Oct 6, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 3

Sensible Biotechnologies $47M Series A Infinimmune $75M Series A Syntax Bio $14.4M Series A+

Pureos BioventuresLatest Sep 30

AnaCardio · €62.5M Series B NovaGo Therapeutics · CHF 24M Series B

3rounds

1led

Biotech 3

Series B 2, Series A 1

Sep 30, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 2, Series A 1

AnaCardio €62.5M Series B NovaGo Therapeutics CHF 24M Series B Tavo Biotherapeutics $17M Series A

Sound BioventuresLatest Sep 30

AnaCardio · €62.5M Series B Breye Therapeutics · €67.5M Series A

3rounds

1led

Biotech 3

Seed 1, Series A 1, Series B 1

Sep 30, 2026

Details

New companies 2 · Follow-on 1

Stages: Seed 1, Series A 1, Series B 1

AnaCardio €62.5M Series B Breye Therapeutics €67.5M Series A Breye Therapeutics €4M Seed

Merck Global Health Innovation FundLatest Sep 24

BigHat Biosciences · $75M Series C Infinimmune · $75M Series A

3rounds

0led

Biotech 3

Seed 1, Series A 1, Series C+ 1

Sep 24, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Series C+ 1

BigHat Biosciences $75M Series C Infinimmune $75M Series A DropGenie Undisclosed Seed+

S32Latest Sep 24

BigHat Biosciences · $75M Series C Basecamp Research · $140M Series C

3rounds

1led

Biotech 3

Series C+ 2, Undisclosed 1

Sep 24, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Undisclosed 1

BigHat Biosciences $75M Series C Basecamp Research $140M Series C Network Bio $50M Strategic

TesiLatest Sep 24

Kasvu Therapeutics · €30M Series A CurifyLabs · $14M Series A

3rounds

0led

Biotech 2Healthtech 1

Series A 2, Seed 1

Sep 24, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Seed 1

Kasvu Therapeutics €30M Series A CurifyLabs $14M Series A Avenue Biosciences $5.7M Seed+

Alderline GroupLatest Sep 23

Enveda · $311M Series E Third Arc Bio · $52M Series A+

3rounds

0led

Biotech 3

Series C+ 2, Series A 1

Sep 23, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series A 1

Enveda $311M Series E Third Arc Bio $52M Series A+Parabilis Medicines $305M Series F

RedalpineLatest Sep 23

Basecamp Research · $140M Series C Apoha · Undisclosed Series A

3rounds

0led

Biotech 2Industrial tech 1

Seed 1, Series A 1, Series C+ 1

Sep 23, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Series C+ 1

Basecamp Research $140M Series C Apoha Undisclosed Series A Helical $10M Seed

Surveyor CapitalLatest Sep 23

Enveda · $311M Series E Adcendo · $75M Series C

3rounds

0led

Biotech 3

Series C+ 3

Sep 23, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 3

Enveda $311M Series E Adcendo $75M Series C Soley Therapeutics $200M Series C

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.